The author of this article, Jim Cramer's Charitable Trust, will begin a position in Cardinal Health, a health-care stock with a $260 price target shortly after the opening bell. The move comes amid concerns about potential risks posed by AI (AI) and potential disruptions to the labor market and enterprise software companies. Following the trade, the trust will own about 1% of Cardinal Health. The author argues that the company generates about 99% of its revenue domestically, protecting it from overseas pressure. Cardinal Health plays a significant role in the U.S. health-Care supply chain by supplying and distributing medicines and medical products to hospitals, retail pharmacies, and clinics. The aging population of Americans over 65 and older has been a significant long-term tailwind for the company, with the company predicting there will be more Americans over age 65 every year for the next three-plus decades. Despite this period of uncertainty, the stock has been strong performer over the past year, trading at just 21 times calendar year 2026 earnings estimates.